Literature DB >> 20071449

Hepatic heme-regulated inhibitor (HRI) eukaryotic initiation factor 2alpha kinase: a protagonist of heme-mediated translational control of CYP2B enzymes and a modulator of basal endoplasmic reticulum stress tone.

Poulomi Acharya1, Jane-Jane Chen, Maria Almira Correia.   

Abstract

We have reported previously that the hepatic heme-regulated inhibitor (HRI)-eukaryotic initiation factor 2 alpha (eIF2 alpha) kinase is activated in acute heme-deficient states, resulting in translational shut-off of global hepatic protein synthesis, including phenobarbital (PB)-mediated induction of CYP2B enzymes in rats. These findings revealed that heme regulates hepatic CYP2B synthesis at the translational level via HRI. As a proof of concept, we have now employed a genetic HRI-knockout (KO) mouse hepatocyte model. In HRI-KO hepatocytes, PB-mediated CYP2B protein induction is no longer regulated by hepatic heme availability and proceeds undeterred even after acute hepatic heme depletion. It is noteworthy that genetic ablation of HRI led to a small albeit significant elevation of basal hepatic endoplasmic reticulum (ER) stress as revealed by the activation of ER stress-inducible RNA-dependent protein kinase-like ER-integral (PERK) eIF2 alpha-kinase, and induction of hepatic protein ubiquitination and ER chaperones Grp78 and Grp94. Such ER stress was further augmented after PB-mediated hepatic protein induction. These findings suggest that HRI normally modulates the basal hepatic ER stress tone. Furthermore, because HRI exists in both human and rat liver in its heme-sensitive form and is inducible by cytochrome P450 inducers such as PB, these findings are clinically relevant to acute heme-deficient states, such as the acute hepatic porphyrias. Activation of this exquisitely sensitive heme sensor would normally protect cells by safeguarding cellular energy and nutrients during acute heme deficiency. However, similar HRI activation in genetically predisposed persons could lead to global translational arrest of physiologically relevant enzymes and proteins, resulting in the severe and often fatal clinical symptoms of the acute hepatic porphyrias.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20071449      PMCID: PMC2845940          DOI: 10.1124/mol.109.061259

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  37 in total

1.  Elucidation of the heme binding site of heme-regulated eukaryotic initiation factor 2alpha kinase and the role of the regulatory motif in heme sensing by spectroscopic and catalytic studies of mutant proteins.

Authors:  Jotaro Igarashi; Motohiko Murase; Aya Iizuka; Fabio Pichierri; Marketa Martinkova; Toru Shimizu
Journal:  J Biol Chem       Date:  2008-05-01       Impact factor: 5.157

2.  Limited heme synthesis in porphobilinogen deaminase-deficient mice impairs transcriptional activation of specific cytochrome P450 genes by phenobarbital.

Authors:  R Jover; F Hoffmann; V Scheffler-Koch; R L Lindberg
Journal:  Eur J Biochem       Date:  2000-12

3.  Translation initiation control by heme-regulated eukaryotic initiation factor 2alpha kinase in erythroid cells under cytoplasmic stresses.

Authors:  L Lu; A P Han; J J Chen
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

4.  Heme-regulated eIF2alpha kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency.

Authors:  A P Han; C Yu; L Lu; Y Fujiwara; C Browne; G Chin; M Fleming; P Leboulch; S H Orkin; J J Chen
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

5.  Heme-regulated eIF2alpha kinase modifies the phenotypic severity of murine models of erythropoietic protoporphyria and beta-thalassemia.

Authors:  An-Ping Han; Mark D Fleming; Jane-Jane Chen
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

6.  The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas.

Authors:  Peichuan Zhang; Barbara McGrath; Sheng'ai Li; Ami Frank; Frank Zambito; Jamie Reinert; Maureen Gannon; Kun Ma; Kelly McNaughton; Douglas R Cavener
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

7.  Heme-regulated inhibitor kinase-mediated phosphorylation of eukaryotic translation initiation factor 2 inhibits translation, induces stress granule formation, and mediates survival upon arsenite exposure.

Authors:  Edward McEwen; Nancy Kedersha; Benbo Song; Donalyn Scheuner; Natalie Gilks; Anping Han; Jane-Jane Chen; Paul Anderson; Randal J Kaufman
Journal:  J Biol Chem       Date:  2005-01-31       Impact factor: 5.157

8.  Chromatin assembly enhances binding to the CYP2B1 phenobarbital-responsive unit (PBRU) of nuclear factor-1, which binds simultaneously with constitutive androstane receptor (CAR)/retinoid X receptor (RXR) and enhances CAR/RXR-mediated activation of the PBRU.

Authors:  J Kim; G Min; B Kemper
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

9.  ATF5 is a highly abundant liver-enriched transcription factor that cooperates with constitutive androstane receptor in the transactivation of CYP2B6: implications in hepatic stress responses.

Authors:  Maya Pascual; M José Gómez-Lechón; José V Castell; Ramiro Jover
Journal:  Drug Metab Dispos       Date:  2008-03-10       Impact factor: 3.922

10.  Hepatic CYP3A suppression by high concentrations of proteasomal inhibitors: a consequence of endoplasmic reticulum (ER) stress induction, activation of RNA-dependent protein kinase-like ER-bound eukaryotic initiation factor 2alpha (eIF2alpha)-kinase (PERK) and general control nonderepressible-2 eIF2alpha kinase (GCN2), and global translational shutoff.

Authors:  Poulomi Acharya; Juan C Engel; Maria Almira Correia
Journal:  Mol Pharmacol       Date:  2009-06-11       Impact factor: 4.436

View more
  14 in total

1.  Liver cytochrome P450 3A endoplasmic reticulum-associated degradation: a major role for the p97 AAA ATPase in cytochrome P450 3A extraction into the cytosol.

Authors:  Poulomi Acharya; Mingxiang Liao; Juan C Engel; Maria Almira Correia
Journal:  J Biol Chem       Date:  2010-11-24       Impact factor: 5.157

2.  Ubiquitin-dependent proteasomal degradation of human liver cytochrome P450 2E1: identification of sites targeted for phosphorylation and ubiquitination.

Authors:  YongQiang Wang; Shenheng Guan; Poulomi Acharya; Dennis R Koop; Yi Liu; Mingxiang Liao; Alma L Burlingame; Maria Almira Correia
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

3.  Liver cytochrome P450 3A ubiquitination in vivo by gp78/autocrine motility factor receptor and C terminus of Hsp70-interacting protein (CHIP) E3 ubiquitin ligases: physiological and pharmacological relevance.

Authors:  Sung-Mi Kim; Poulomi Acharya; Juan C Engel; Maria Almira Correia
Journal:  J Biol Chem       Date:  2010-09-06       Impact factor: 5.157

Review 4.  Cytochrome P450 regulation: the interplay between its heme and apoprotein moieties in synthesis, assembly, repair, and disposal.

Authors:  Maria Almira Correia; Peter R Sinclair; Francesco De Matteis
Journal:  Drug Metab Rev       Date:  2010-09-23       Impact factor: 4.518

5.  MicroRNA-122-3p plays as the target of long non-coding RNA LINC00665 in repressing the progress of arthritis.

Authors:  Zhiyan Wang; Qijun Tian; Yumei Tian; Zhonghua Zheng
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 6.  The eIF2α kinases: their structures and functions.

Authors:  Neysan Donnelly; Adrienne M Gorman; Sanjeev Gupta; Afshin Samali
Journal:  Cell Mol Life Sci       Date:  2013-01-26       Impact factor: 9.261

7.  De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation.

Authors:  Dongxue Mao; Chloe M Reuter; Maura R Z Ruzhnikov; Anita E Beck; Emily G Farrow; Lisa T Emrick; Jill A Rosenfeld; Katherine M Mackenzie; Laurie Robak; Matthew T Wheeler; Lindsay C Burrage; Mahim Jain; Pengfei Liu; Daniel Calame; Sébastien Küry; Martin Sillesen; Klaus Schmitz-Abe; Davide Tonduti; Luigina Spaccini; Maria Iascone; Casie A Genetti; Mary K Koenig; Madeline Graf; Alyssa Tran; Mercedes Alejandro; Brendan H Lee; Isabelle Thiffault; Pankaj B Agrawal; Jonathan A Bernstein; Hugo J Bellen; Hsiao-Tuan Chao
Journal:  Am J Hum Genet       Date:  2020-03-19       Impact factor: 11.025

Review 8.  The eIF2-alpha kinase HRI: a potential target beyond the red blood cell.

Authors:  Nicholas Burwick; Bertal H Aktas
Journal:  Expert Opin Ther Targets       Date:  2017-10-30       Impact factor: 6.902

Review 9.  The integrated stress response.

Authors:  Karolina Pakos-Zebrucka; Izabela Koryga; Katarzyna Mnich; Mila Ljujic; Afshin Samali; Adrienne M Gorman
Journal:  EMBO Rep       Date:  2016-09-14       Impact factor: 8.807

10.  Utility of B-13 progenitor-derived hepatocytes in hepatotoxicity and genotoxicity studies.

Authors:  Philip M E Probert; Git W Chung; Simon J Cockell; Loranne Agius; Pasquale Mosesso; Steven A White; Fiona Oakley; Colin D A Brown; Matthew C Wright
Journal:  Toxicol Sci       Date:  2013-11-14       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.